Study Casts Doubt on Use of Beta Blockers Post-Heart Attack, Especially for Women
The study found women with normal heart function taking beta-blockers after uncomplicated heart attacks were three times more likely to die, sparking debate over treatment guidelines.
- On Aug. 30, the National Centre for Cardiovascular Research in Spain reported that beta-blockers do not reduce death, second heart attack, or heart failure risk in many survivors; the Ministry of Health urged patients not to stop use without consulting doctors.
- Dr. Borja Ibáñez said the practice dates back more than four decades, with beta‑blockers standard for over 80% of uncomplicated myocardial infarction patients, studied in 8,438 patients across 109 healthcare centers.
- For women with normal EF, the trial found those with left ventricular ejection fraction above 50 percent had nearly 3% higher death risk on beta-blockers, especially high-dose recipients.
- Researchers warn that the study could affect guideline recommendations as Spanish cardiology researchers estimate 1.2 million people in Spain may take unnecessary beta-blockers, prompting potential changes to international clinical guidelines.
- Health officials urged caution as Spain's Ministry of Health and National Centre for Cardiovascular Research in Spain clash over beta‑blocker guidelines, with patients advised to consult their doctors before changes due to roles in arrhythmia and high blood pressure.
Insights by Ground AI
Does this summary seem wrong?
24 Articles
24 Articles

+20 Reposted by 20 other sources
Study Casts Doubt on Use of Beta Blockers Post-Heart Attack, Especially for Women
Key Takeaways
·Missoula, United States
Read Full ArticleSpain divided over beta-blocker treatment for heart-attack survivors
New research by Spanish cardiologists suggests that it could be harmful for women to take beta-blockers after a heart-attack, but the Spanish Ministry of Health is critical of the study and warns patients that they shouldn't stop taking them.
·Spain
Read Full ArticleA new study calls into question the routine use of beta-blockers after a heart attack, showing few significant benefits and a potential increase in adverse events, particularly in women. Cardiologist Dr. Olivier Hoffman sheds light on these findings.
Coverage Details
Total News Sources24
Leaning Left5Leaning Right3Center5Last UpdatedBias Distribution38% Left, 38% Center
Bias Distribution
- 38% of the sources lean Left, 38% of the sources are Center
38% Center
L 38%
C 38%
R 23%
Factuality
To view factuality data please Upgrade to Premium